Clinical Trial Update: Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced CONstipation: Clinical Outcomes and Patient Experience

View source ↗

Summary

This entry reports an ongoing clinical trial evaluating naldemedine for opioid-induced constipation in cancer patients, focusing on clinical outcomes and patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Opioid-induced Constipation

Drugs mentioned

• SYMPROIC (NALDEMEDINE)

Snippet

Sponsor: Professor Monique A. H. Steegers | Conditions: Cancer, Opioid Induced Constipation (OIC) | Status: RECRUITING